Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shen-Shuai-II-Recipe is a Traditional Chinese Medicine (TCM) herbal formula primarily investigated for the treatment of chronic kidney disease (CKD) and chronic renal failure. It typically consists of a combination of herbs including *Rheum palmatum* (Rhubarb), *Salvia miltiorrhiza* (Danshen), *Astragalus membranaceus* (Huangqi), *Ligusticum chuanxiong* (Chuanxiong), *Carthamus tinctorius* (Honghua), and *Achyranthes bidentata* (Niuxi). The formula is designed to delay the progression of renal fibrosis and improve kidney function. Its mechanism of action involves the inhibition of the TGF-β1/Smad signaling pathway, reduction of oxidative stress, and modulation of inflammatory cytokines. It has been studied in clinical settings in China, often as an adjuvant therapy to standard care, and is particularly associated with research conducted at Longhua Hospital.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shen-Shuai-II-Recipe.